New Key Statistics Module, Z-Score and F-Score
NAS:PRQR Key Ratios
| Market Cap $ M | 161.08 |
| Enterprise Value $ M | 54.15 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.57 |
| Price/Sales | 22.76 |
| Price/Free Cash Flow | 7.47 |
| Price/Owner Earnings | 6.71 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -0.38 |
| Beneish M-Score | -4.99 |
| 10-y EBITDA Growth Rate % | 0.40 |
| 5-y EBITDA Growth Rate % | 20.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.89 |
| EV-to-EBITDA | -2.09 |
| PEG | -- |
| Shares Outstanding M | 81.35 |
| Net Margin (%) | -429.75 |
| Operating Margin % | -532.75 |
| Pre-tax Margin (%) | -425.12 |
| Quick Ratio | 3.54 |
| Current Ratio | 3.54 |
| ROA % (ttm) | -18.63 |
| ROE % (ttm) | -53.17 |
| ROIC % (ttm) | -73.97 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.99 |
PRQR Number of Guru Trades
PRQR Volume of Guru Trades
Gurus Latest Trades with NAS:PRQR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRQR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ProQR Therapeutics NV Insider Transactions
No Available Data
News about NAS:PRQR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers